Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Isotretinoin effects on bone.

J J DiGiovanna1

  • 1Division of Dermatopharmacology, Department of Dermatology, Brown University School of Medicine/Rhode Island Hospital, 593 Eddy St., Providence, RI 02903, USA. John_DiGiovanna_MD@Brown.edu

Journal of the American Academy of Dermatology
|October 19, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thyroid nodules in xeroderma pigmentosum patients: a feature of premature aging.

Journal of endocrinological investigation·2020
Same author

Molecular diagnosis of xeroderma pigmentosum variant in an isolated population: the interface between precision medicine and public health.

The British journal of dermatology·2017
Same author

Activated STING in a vascular and pulmonary syndrome.

The New England journal of medicine·2014
Same author

Burning issues in the diagnosis of xeroderma pigmentosum.

The British journal of dermatology·2013
Same author

Adverse effects of trichothiodystrophy DNA repair and transcription gene disorder on human fetal development.

Clinical genetics·2009
Same author

Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations.

Journal of medical genetics·2008
Same journal

Hypoactive Sexual Desire Disorder in Menopausal Women: Dermatologic Implications of Antiandrogen and Testosterone Therapy.

Journal of the American Academy of Dermatology·2026
Same journal

Incise parallel, section perpendicular to the dermatoglyphs for diagnosis of acral melanocytic lesions-A comment on Thakker et al.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Xue et al, "Defining super-responders is not the same as predicting rituximab response in pemphigus".

Journal of the American Academy of Dermatology·2026
Same journal

Comment on Nie et al. (2026) 'Suicidality Reports in Acne Patients Treated with Isotretinoin and Concomitant Antidepressants: A Descriptive Analysis of FDA Adverse Event Reporting System Data'.

Journal of the American Academy of Dermatology·2026
Same journal

Defining super-responders is not the same as predicting rituximab response in pemphigus.

Journal of the American Academy of Dermatology·2026
Same journal

Eosinophilic fasciitis induced by checkpoint inhibitors: a retrospective multicenter case-series, comparison with eosinophilic fasciitis unrelated to checkpoint inhibition and literature review.

Journal of the American Academy of Dermatology·2026
See all related articles

Isotretinoin is effective for many conditions but can harm bones. Careful monitoring is needed to manage side effects like premature epiphyseal closure in children and hyperostosis in adults.

Area of Science:

  • Pharmacology
  • Orthopedics
  • Dermatology

Background:

  • Isotretinoin is a widely used medication with proven efficacy across various disorders.
  • Adverse effects on bone are a significant limitation to isotretinoin therapy.
  • Understanding these skeletal side effects is crucial for patient management.

Purpose of the Study:

  • To review the known adverse effects of isotretinoin on bone development and structure.
  • To emphasize the importance of monitoring skeletal changes during isotretinoin treatment.
  • To provide guidance for managing isotretinoin's bone-related toxicities.

Main Methods:

  • Literature review of studies on isotretinoin and bone health.
  • Analysis of documented cases of skeletal side effects in pediatric and adult populations.

Related Experiment Videos

  • Synthesis of current knowledge on isotretinoin's impact on bone.

    • Main Results:

    • High-dose isotretinoin exposure in children can lead to premature epiphyseal closure.
    • Long-term isotretinoin therapy in adults is associated with hyperostosis and other bone changes.
    • These bone effects can be managed with careful surveillance and expert clinical judgment.

    Conclusions:

    • Isotretinoin's benefits must be weighed against its potential for skeletal toxicity.
    • Continuous monitoring for bone abnormalities is essential for safe and effective isotretinoin use.
    • Expert management can mitigate risks, allowing for prolonged therapeutic benefit with minimized toxicity.